611 related articles for article (PubMed ID: 32124950)
1. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.
Dong Z; Yang J; Li L; Tan L; Shi P; Zhang J; Zhong X; Ge L; Wu Z; Cui H
Int J Oncol; 2020 Mar; 56(3):728-742. PubMed ID: 32124950
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells.
Dong Z; Zhong X; Lei Q; Chen F; Cui H
Cell Signal; 2019 Aug; 60():100-113. PubMed ID: 31004738
[TBL] [Abstract][Full Text] [Related]
3. SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.
Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
[TBL] [Abstract][Full Text] [Related]
4. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract][Full Text] [Related]
6. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.
Kim HS; Xiao C; Wang RH; Lahusen T; Xu X; Vassilopoulos A; Vazquez-Ortiz G; Jeong WI; Park O; Ki SH; Gao B; Deng CX
Cell Metab; 2010 Sep; 12(3):224-36. PubMed ID: 20816089
[TBL] [Abstract][Full Text] [Related]
7. Forkhead box protein O3 suppresses uveal melanoma development by increasing the expression of Bcl‑2‑like protein 11 and cyclin‑dependent kinase inhibitor 1B.
Yan F; Liao R; Lin S; Deng X; Little PJ; Zheng W
Mol Med Rep; 2018 Feb; 17(2):3109-3114. PubMed ID: 29257235
[TBL] [Abstract][Full Text] [Related]
8. NOVA1 acts as an oncogene in melanoma via regulating FOXO3a expression.
Yu X; Zheng H; Chan MTV; Wu WKK
J Cell Mol Med; 2018 May; 22(5):2622-2630. PubMed ID: 29498217
[TBL] [Abstract][Full Text] [Related]
9. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.
Choe M; Brusgard JL; Chumsri S; Bhandary L; Zhao XF; Lu S; Goloubeva OG; Polster BM; Fiskum GM; Girnun GD; Kim MS; Passaniti A
J Cell Biochem; 2015 Oct; 116(10):2210-26. PubMed ID: 25808624
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
11. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer.
Liu J; Duan Z; Guo W; Zeng L; Wu Y; Chen Y; Tai F; Wang Y; Lin Y; Zhang Q; He Y; Deng J; Stewart RL; Wang C; Lin PC; Ghaffari S; Evers BM; Liu S; Zhou MM; Zhou BP; Shi J
Nat Commun; 2018 Dec; 9(1):5200. PubMed ID: 30518851
[TBL] [Abstract][Full Text] [Related]
12. FOXO3A-induced LINC00926 suppresses breast tumor growth and metastasis through inhibition of PGK1-mediated Warburg effect.
Chu Z; Huo N; Zhu X; Liu H; Cong R; Ma L; Kang X; Xue C; Li J; Li Q; You H; Zhang Q; Xu X
Mol Ther; 2021 Sep; 29(9):2737-2753. PubMed ID: 33940159
[TBL] [Abstract][Full Text] [Related]
13. microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.
Kim S; Lee E; Jung J; Lee JW; Kim HJ; Kim J; Yoo HJ; Lee HJ; Chae SY; Jeon SM; Son BH; Gong G; Sharan SK; Chang S
Oncogene; 2018 May; 37(22):2982-2991. PubMed ID: 29527004
[TBL] [Abstract][Full Text] [Related]
14. SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
Yu Y; Peng K; Li H; Zhuang R; Wang Y; Li W; Yu S; Liang L; Xu X; Liu T
Oncol Rep; 2018 May; 39(5):2235-2242. PubMed ID: 29565456
[TBL] [Abstract][Full Text] [Related]
15. Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis-A therapeutic implication in inflammatory bone resorption.
Hou KL; Lin SK; Chao LH; Hsiang-Hua Lai E; Chang CC; Shun CT; Lu WY; Wang JH; Hsiao M; Hong CY; Kok SH
Biofactors; 2017 Mar; 43(2):170-180. PubMed ID: 27534902
[TBL] [Abstract][Full Text] [Related]
16. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
18. FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation.
Wang X; Ji T; Li X; Qu X; Bai S
Oxid Med Cell Longev; 2021; 2021():5565761. PubMed ID: 34122724
[TBL] [Abstract][Full Text] [Related]
19. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
[TBL] [Abstract][Full Text] [Related]
20. FOXO3a orchestrates glioma cell responses to starvation conditions and promotes hypoxia-induced cell death.
Brucker DP; Maurer GD; Harter PN; Rieger J; Steinbach JP
Int J Oncol; 2016 Dec; 49(6):2399-2410. PubMed ID: 27840901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
